Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
It is in Phase 3 investigational trials as a "next generation" weight loss medication with potentially fewer side effects compared to single-receptor predecessors like Semaglutide or dual receptor meds like Tirzepatide
AOD 9604 is more targeted
The peptide is classified as a research compound and is not approved for treatment of obesity or any medical condition
What are the side effects of peptide AOD 9604
Full-length growth hormone stimulates fat breakdown, yes
Faster Hair Growth
US$ 21.05
US$ 20.32
US$ 26.86
US$ 24.12
US$ 23.10
US$ 24.83
